Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 520
5
Diseases
17
Unique genes
0.153
Avg. similarity score
Double outlet right ventricle
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Double outlet right ventricle
Transposition of the great arteries
Right atrial isomerism
Right isomerism
Congenitally uncorrected transposition of the great arteries
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Double outlet right ventricle | 4 | 4 | 8 |
| Transposition of the great arteries | 4 | 4 | 12 |
| Right atrial isomerism | 3 | 3 | 3 |
| Right isomerism | 3 | 3 | 1 |
| Congenitally uncorrected transposition of the great arteries | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| GDF1 | 4 / 5 | Double outlet right ventricle, Right atrial isomerism, Right isomerism, Transposition of the great arteries |
| CERS1 | 3 / 5 | Double outlet right ventricle, Right atrial isomerism, Transposition of the great arteries |
| CFC1 | 3 / 5 | Congenitally uncorrected transposition of the great arteries, Double outlet right ventricle, Transposition of the great arteries |
| UPF1 | 2 / 5 | Right atrial isomerism, Transposition of the great arteries |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | Reactome | 2 / 7 | 202× | 3.94e-5 | 9.05e-4 ✓ sig. |
| Physiological factors | Reactome | 2 / 12 | 118× | 1.23e-4 | 2.24e-3 ✓ sig. |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | Reactome | 2 / 14 | 101× | 1.70e-4 | 2.89e-3 ✓ sig. |
| Metabolism of folate and pterines | Reactome | 2 / 17 | 83.1× | 2.53e-4 | 3.95e-3 ✓ sig. |
| Antifolate resistance | KEGG | 2 / 30 | 47.1× | 8.01e-4 | 9.57e-3 ✓ sig. |
| Folate transport and metabolism | KEGG | 2 / 31 | 45.6× | 8.56e-4 | 1.01e-2 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 3 / 298 | 7.1× | 7.94e-3 | 4.94e-2 ✓ sig. |
| Factors involved in megakaryocyte development and platelet production | Reactome | 2 / 99 | 14.3× | 8.44e-3 | 5.12e-2 |
| TGF-beta signaling pathway | KEGG | 2 / 108 | 13.1× | 9.98e-3 | 5.67e-2 |
| Thyroid hormone signaling pathway | KEGG | 2 / 122 | 11.6× | 1.26e-2 | 6.55e-2 |
| CD28 co-stimulation | Reactome | 1 / 9 | 78.5× | 1.27e-2 | 6.57e-2 |
| Signaling by Activin | Reactome | 1 / 11 | 64.2× | 1.55e-2 | 7.39e-2 |
| Transcriptional regulation by RUNX2 | Reactome | 1 / 12 | 58.9× | 1.69e-2 | 7.78e-2 |
| FCGR activation | Reactome | 1 / 12 | 58.9× | 1.69e-2 | 7.78e-2 |
| PECAM1 interactions | Reactome | 1 / 12 | 58.9× | 1.69e-2 | 7.78e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| heart development | GO:0007507 | 6 / 273 | 24.2× | 9.95e-8 | 1.26e-5 ✓ sig. |
| cardiac muscle tissue morphogenesis | GO:0055008 | 3 / 13 | 254× | 1.78e-7 | 2.05e-5 ✓ sig. |
| atrial septum morphogenesis | GO:0060413 | 3 / 13 | 254× | 1.78e-7 | 2.05e-5 ✓ sig. |
| right ventricular cardiac muscle tissue morphogenesis | GO:0003221 | 2 / 2 | 1,099× | 7.79e-7 | 6.99e-5 ✓ sig. |
| outflow tract septum morphogenesis | GO:0003148 | 3 / 28 | 118× | 2.02e-6 | 1.53e-4 ✓ sig. |
| embryonic heart tube anterior/posterior pattern specification | GO:0035054 | 2 / 3 | 733× | 2.34e-6 | 1.72e-4 ✓ sig. |
| cardiac muscle cell differentiation | GO:0055007 | 3 / 30 | 110× | 2.50e-6 | 1.82e-4 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 8 / 1,208 | 7.3× | 4.28e-6 | 2.80e-4 ✓ sig. |
| atrioventricular node development | GO:0003162 | 2 / 6 | 366× | 1.17e-5 | 6.12e-4 ✓ sig. |
| cell differentiation | GO:0030154 | 7 / 1,051 | 7.3× | 2.06e-5 | 9.46e-4 ✓ sig. |
| heart morphogenesis | GO:0003007 | 3 / 61 | 54.1× | 2.18e-5 | 9.86e-4 ✓ sig. |
| outflow tract morphogenesis | GO:0003151 | 3 / 63 | 52.3× | 2.40e-5 | 1.06e-3 ✓ sig. |
| cardiac ventricle morphogenesis | GO:0003208 | 2 / 10 | 220× | 3.49e-5 | 1.41e-3 ✓ sig. |
| mesenchymal cell differentiation | GO:0048762 | 2 / 13 | 169× | 6.04e-5 | 2.13e-3 ✓ sig. |
| cardiac right ventricle morphogenesis | GO:0003215 | 2 / 13 | 169× | 6.04e-5 | 2.13e-3 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Right atrial isomerism | Transposition of the great arteries | 0.231 | 3 | 3.55e-10 | 3.18e-9 ✓ sig. |
| Double outlet right ventricle | Transposition of the great arteries | 0.167 | 3 | 1.99e-8 | 1.53e-7 ✓ sig. |
| Double outlet right ventricle | Right atrial isomerism | 0.200 | 2 | 7.00e-7 | 4.35e-6 ✓ sig. |
| Right atrial isomerism | Right isomerism | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Congenitally uncorrected transposition of the great arteries | Double outlet right ventricle | 0.111 | 1 | 5.17e-4 | 9.13e-4 ✓ sig. |
| Double outlet right ventricle | Right isomerism | 0.111 | 1 | 5.17e-4 | 9.13e-4 ✓ sig. |
| Congenitally uncorrected transposition of the great arteries | Transposition of the great arteries | 0.077 | 1 | 7.75e-4 | 1.25e-3 ✓ sig. |
| Right isomerism | Transposition of the great arteries | 0.077 | 1 | 7.75e-4 | 1.25e-3 ✓ sig. |